QatarBusinessToday.com
No Result
View All Result
  • About Us
  • Contact Us
  • Business
  • Energy
  • Finance
  • Healthcare
  • Real Estate
  • Travel
  • Tech
  • Middle East
  • Press Releases
Submit a Press Release
  • Business
  • Energy
  • Finance
  • Healthcare
  • Real Estate
  • Travel
  • Tech
  • Middle East
  • Press Releases
No Result
View All Result
QatarBusinessToday.com
Submit PR
Home Press Releases

Plasma Fractionation Market Worth $46.9 Billion by 2029 – Exclusive Report by Meticulous Research®

Newsroom by Newsroom
August 13, 2022
Plasma Fractionation Market Worth $46.9 Billion by 2029 – Exclusive Report by Meticulous Research®
Share on FacebookShare on Twitter


 


(EMAILWIRE.COM, August 13, 2022 ) According to a new market research report, “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) – Global Forecast to 2029”, published by Meticulous Research®, the plasma fractionation market is expected to grow at a CAGR of 7.1% from 2022 to reach $46.9 billion by 2029.

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5117

The separation, extraction, and purification of specific components from the plasma are called the fractionation process. The products extracted from the plasma are used for treating various disorders. Immunoglobulins are useful in treating autoimmune diseases and increasing the immune response. Clotting factors are used to treat blood disorders such as hemophilia and albumins, which are useful in cases of depleted albumin levels or during fluid loss. As the prevalence of hemophilia and autoimmune disease increases, the demand for plasma-derived products will rise in the coming years.

Impact of COVID-19 on the Plasma Fractionation Market

Limited data suggest that convalescent plasma and hyperimmune globulin may have benefits in the COVID-19 illness. Therefore, evaluating these therapies in the context of a clinical trial and expanded access program is important. Hence, well-controlled clinical trials are conducted to evaluate the safety and efficacy of plasma treatment. Some of these include;

In China, in February 2020, an interventional clinical trial was started to evaluate the efficacy of intravenous immunoglobulin therapy in patients with severe 2019- nCoV pneumonia with 80 participants.
In France, in April 2020, an interventional clinical trial was started regarding early treatment with polyvalent immunoglobulin in managing acute respiratory distress syndrome associated with SARS-CoV-2 infections. Over 138 participants were enrolled in the study.
In the U.S., in April 2020, a clinical trial ‘The COVID-IG trial: intramuscular (IM) injection of COVID-19-convalescent hyperimmune immunoglobulin (COVID-IG) to prevent SARS-CoV-2 infection in high-risk persons’ was carried out.
Thus, the clinical trials, being an initial part of the evolution of treatment during COVID-19, positively impact the plasma fractionation market.

The plasma fractionation market is segmented based on product, application, and end user. The study also evaluates industry competitors and analyzes the regional and country markets.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5117

Based on product, the immunoglobulins segment is estimated to account for the largest share of the plasma fractionation market in 2022. The segment is also expected to grow at the highest CAGR during the forecast. The large share is mainly attributed to the adoption of plasma-derived immunoglobulins to treat various immunological disorders such as autoimmunity diseases, primary and secondary immunodeficiency, and neurological disorders. Further, the COVID-19 disease resulted in the growth of studies regarding the use of hyper immunoglobulins derived from COVID-19 recovered patients’ plasma to treat the disease.

Based on application, the neurology segment is expected to grow at the highest CAGR during the forecast period due to the rise in the prevalence of neurological disorders and plasma-derived products for treating these disorders.

Based on end user, the hospitals & clinics segment is estimated to command the largest share of the market in 2022. The growing need for therapies for immunodeficiency disorders, the growing number of hospitals & healthcare expenditure, and the largest consumption of plasma-derived products by hospitals & clinics are some of the major factors driving the growth of this segment.

Geographically, North America is estimated to dominate the overall plasma fractionation market in 2022, followed by Europe and Asia-Pacific. The growing number of respiratory diseases will increase the adoption of coagulation factors, which drives the market for plasma fractionation in North America. Also, a surge in consumption of immunoglobulins, an increase in plasma collection centers, the capability to supply plasma due to the feasibility of plasma collection & distribution, and the presence of key players contribute to the regional market’s growth.

Quick Buy – “Plasma Fractionation Market by Product [Immunoglobulins (Intravenous, Subcutaneous), Coagulation Factors, Albumin], Application (Immunology, Hematology, Neurology), and End User (Hospital, Clinical Research Lab, Academic Institutes) – Forecast to 2029” Research Report: https://www.meticulousresearch.com/Checkout/75893588

However, Asia-Pacific is expected to grow at the fastest CAGR during the forecast period. The factors driving the growth of the Asia-Pacific market are the rising consumption of plasma-derived products, the strategic developments made by the companies in this region, the presence of leading players, and contract fractionation agreements between the countries.

The report also includes an extensive assessment of the product portfolio, geographic analysis, and key strategic developments in the industry’s leading market participants over the past four years (2019–2022). In recent years, the plasma fractionation market has witnessed several product approvals, new product launches, partnerships, agreements, & collaborations, expansions, and acquisitions. For instance, in February 2022, Grifols, S.A. (Spain) entered into an agreement with Endpoint Health, Inc. (U.S.) to develop and commercialize an Antithrombin III (AT-III) therapy to treat Sepsis. Also, in August 2021, Octopharma AG (Switzerland) received U.S. FDA approval for Octagam 10% [Immune Globulin Intravenous (Human)] for the treatment of adult dermatomyositis (DM).

Some of the key players operating in this market are CSL Limited (Australia), Grifols, S.A. (Spain), Octopharma AG (Switzerland), Kedrion S.P.A. (Italy), Shire plc (U.K.), Biotest AG (Germany), China Biologic Products Holdings, Inc. (China), Bio Products Laboratory Ltd (U.K.), Japan Blood Products Organization (Japan), and Intas Pharmaceuticals Ltd. (India).

To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/plasma-fractionation-market-5117



Source link

Previous Post

Over-the-Top Services Market Size Gaining : USD 156.9 billion by 2024

Next Post

OmanNews.Club™ Adds to Arab Newswire Media Lists for Press Release Distribution to GCC/MENA Countries

Related Posts

Pickleball Market expected to reach USD 2.64 Billion by 2029 at a CAGR of 10.2 percent
Press Releases

Pickleball Market expected to reach USD 2.64 Billion by 2029 at a CAGR of 10.2 percent

October 1, 2023
Voltage Transformer Market expected to reach USD 37.17 Billion by 2029 at a CAGR of 7.2 percent
Press Releases

Voltage Transformer Market expected to reach USD 37.17 Billion by 2029 at a CAGR of 7.2 percent

October 1, 2023
Payday Loans Market expected to Reach USD 51.98 Billion by 2029 at a CAGR of 4.42 percent
Press Releases

Payday Loans Market expected to Reach USD 51.98 Billion by 2029 at a CAGR of 4.42 percent

October 1, 2023
Diamond Wire Saw Market expected to reach USD 1.70 Billion by 2029 at a CAGR of 5.1 percent
Press Releases

Diamond Wire Saw Market expected to reach USD 1.70 Billion by 2029 at a CAGR of 5.1 percent

October 1, 2023
Medical Device Technologies Market to reach USD 775.38 Billion by 2029 at a growth rate of 5.6 percent over the forecast period
Press Releases

Medical Device Technologies Market to reach USD 775.38 Billion by 2029 at a growth rate of 5.6 percent over the forecast period

September 30, 2023
Exploring Growth Prospects: Market Research on Photocatalytic Coatings
Press Releases

Exploring Growth Prospects: Market Research on Photocatalytic Coatings

September 30, 2023

Recommended Stories

Electrical Services Market to hit USD 175.28 Bn by 2029 at a CAGR of 6.2 during the forecast period, Market share and Size

Electrical Services Market to hit USD 175.28 Bn by 2029 at a CAGR of 6.2 during the forecast period, Market share and Size

September 29, 2023

Asia Pacific: The Epicenter of Growth in Rockets and Missiles Market

August 7, 2023

Qatar: QSE closes in positive zone as domestic funds’ net buying strengthens – ZAWYA

August 21, 2023

Popular Stories

  • ZainTech partners with LigaData to deliver data-driven digital services in MENA

    ZainTech partners with LigaData to deliver data-driven digital services in MENA

    0 shares
    Share 0 Tweet 0
  • Exchange goods, vehicles, or property for crypto on Bazaars

    0 shares
    Share 0 Tweet 0
  • Rastec Real Estate holds groundbreaking for mixed-use building project

    0 shares
    Share 0 Tweet 0
  • Qatari Ministry, Meta partnership seeks growth of digital innovation ecosystem

    0 shares
    Share 0 Tweet 0
  • Al Futtaim Group Real Estate partners with TIER Mobility for micro-mobility services at Dubai Festival City – MEConstructionNews.com

    0 shares
    Share 0 Tweet 0

Qatar Business Today™ publishes and aggregates business, socio-economic, Tech and industrial news on Qatar, Middle East and North Africa (MENA)..

Press release distribution services:

We provide press release distribution to media in Qatar, the Arab world and the GCC/MENA regions. Submit a press release today, contact us.

Recent News

.
  • Voltage Transformer Market expected to reach USD 37.17 Billion by 2029 at a CAGR of 7.2 percent
  • Pickleball Market expected to reach USD 2.64 Billion by 2029 at a CAGR of 10.2 percent
  • Diamond Wire Saw Market expected to reach USD 1.70 Billion by 2029 at a CAGR of 5.1 percent
  • Payday Loans Market expected to Reach USD 51.98 Billion by 2029 at a CAGR of 4.42 percent

Categories

Business
Energy
Finance
Healthcare
Real Estate
Travel
Tech
Middle East
Press Releases

Subscribe to Our Newsletter

    Qatar Business Today™ is part of GroupWeb Media Network. © 2023 GroupWeb Media LLC
    • About Us
    • Contact Us
    • Submit a Press Release
    No Result
    View All Result
    • Business
    • Energy
    • Finance
    • Healthcare
    • Real Estate
    • Tech
    • Travel
    • Middle East
    • Press Releases
    • About Us
      • Contact Us
      • Submit a Press Release

    Qatar Business Today™ is part of GroupWeb Media Network. © 2023 GroupWeb Media LLC